T1	intervention 13 34	essential oil mixture
T2	condition 38 52	skin reactions
T3	eligibility 56 103	women undergoing radiotherapy for breast cancer
T4	control 193 206	standard care
T5	No-of-participants 302 304	24
T6	duration 462 469	1 month
T7	outcome-Measure 485 508	Weekly skin assessments
T8	outcome-Measure 543 563	patient satisfaction
T9	outcome-Measure 568 589	quality of life (QOL)
T10	outcome 678 712	skin, QOL, or patient satisfaction
T11	outcome 780 784	skin
T12	outcome 821 824	QOL
T13	outcome 854 874	patient satisfaction
T14	outcome 948 970	skin protectant effect
